124 related articles for article (PubMed ID: 35635894)
1. CTK7A, a curcumin derivative, can be a potential candidate for targeting HIF-1α/p300 complex: Evidences from in vitro and computational studies.
Rath S; Jena AB; Bhattacharyya A; Dandapat J
Biophys Chem; 2022 Aug; 287():106828. PubMed ID: 35635894
[TBL] [Abstract][Full Text] [Related]
2. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1).
Schmid T; Zhou J; Köhl R; Brüne B
Biochem J; 2004 May; 380(Pt 1):289-95. PubMed ID: 14992692
[TBL] [Abstract][Full Text] [Related]
3. P300/CBP Regulates HIF-1-Dependent Sympathetic Activation and Hypertension by Intermittent Hypoxia.
Wang N; Su X; Sams D; Prabhakar NR; Nanduri J
Am J Respir Cell Mol Biol; 2024 Feb; 70(2):110-118. PubMed ID: 37874694
[TBL] [Abstract][Full Text] [Related]
4. Insights from molecular dynamics simulations and steered molecular dynamics simulations to exploit new trends of the interaction between HIF-1α and p300.
Yu Z; Liu Y; Zhu J; Han J; Tian X; Han W; Zhao L
J Biomol Struct Dyn; 2020 Jan; 38(1):1-12. PubMed ID: 30784357
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha.
Fath DM; Kong X; Liang D; Lin Z; Chou A; Jiang Y; Fang J; Caro J; Sang N
J Biol Chem; 2006 May; 281(19):13612-13619. PubMed ID: 16543236
[TBL] [Abstract][Full Text] [Related]
6. Roles of coactivators in hypoxic induction of the erythropoietin gene.
Wang F; Zhang R; Wu X; Hankinson O
PLoS One; 2010 Apr; 5(4):e10002. PubMed ID: 20368990
[TBL] [Abstract][Full Text] [Related]
7. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
Na YR; Han KC; Park H; Yang EG
Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone/lysine acetyltransferase activity kills CoCl
Rath S; Das L; Kokate SB; Ghosh N; Dixit P; Rout N; Singh SP; Chattopadhyay S; Ashktorab H; Smoot DT; Swamy MM; Kundu TK; Crowe SE; Bhattacharyya A
Int J Biochem Cell Biol; 2017 Jan; 82():28-40. PubMed ID: 27890795
[TBL] [Abstract][Full Text] [Related]
9. HIF-1alpha: a valid therapeutic target for tumor therapy.
Hong SS; Lee H; Kim KW
Cancer Res Treat; 2004 Dec; 36(6):343-53. PubMed ID: 20368827
[TBL] [Abstract][Full Text] [Related]
10. Histone acetyltransferase P300 deficiency promotes ferroptosis of vascular smooth muscle cells by activating the HIF-1α/HMOX1 axis.
Shi J; Wang QH; Wei X; Huo B; Ye JN; Yi X; Feng X; Fang ZM; Jiang DS; Ma MJ
Mol Med; 2023 Jul; 29(1):91. PubMed ID: 37415103
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions.
Lee JW; Bae SH; Jeong JW; Kim SH; Kim KW
Exp Mol Med; 2004 Feb; 36(1):1-12. PubMed ID: 15031665
[TBL] [Abstract][Full Text] [Related]
12. p300 and p53 levels determine activation of HIF-1 downstream targets in invasive breast cancer.
Vleugel MM; Shvarts D; van der Wall E; van Diest PJ
Hum Pathol; 2006 Aug; 37(8):1085-92. PubMed ID: 16867872
[TBL] [Abstract][Full Text] [Related]
13. Complex regulation of the transactivation function of hypoxia-inducible factor-1 alpha by direct interaction with two distinct domains of the CREB-binding protein/p300.
Ruas JL; Berchner-Pfannschmidt U; Malik S; Gradin K; Fandrey J; Roeder RG; Pereira T; Poellinger L
J Biol Chem; 2010 Jan; 285(4):2601-9. PubMed ID: 19880525
[TBL] [Abstract][Full Text] [Related]
14. PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia.
Xenaki G; Ontikatze T; Rajendran R; Stratford IJ; Dive C; Krstic-Demonacos M; Demonacos C
Oncogene; 2008 Oct; 27(44):5785-96. PubMed ID: 18574470
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity.
Kato H; Tamamizu-Kato S; Shibasaki F
J Biol Chem; 2004 Oct; 279(40):41966-74. PubMed ID: 15280364
[TBL] [Abstract][Full Text] [Related]
16. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
[TBL] [Abstract][Full Text] [Related]
17. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1.
Bhattacharya S; Michels CL; Leung MK; Arany ZP; Kung AL; Livingston DM
Genes Dev; 1999 Jan; 13(1):64-75. PubMed ID: 9887100
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2.
Freedman SJ; Sun ZY; Kung AL; France DS; Wagner G; Eck MJ
Nat Struct Biol; 2003 Jul; 10(7):504-12. PubMed ID: 12778114
[TBL] [Abstract][Full Text] [Related]
19. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
Yoon H; Lim JH; Cho CH; Huang LE; Park JW
Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
[TBL] [Abstract][Full Text] [Related]
20. Structural Elucidation and Synthesis of Eudistidine A: An Unusual Polycyclic Marine Alkaloid that Blocks Interaction of the Protein Binding Domains of p300 and HIF-1α.
Chan ST; Patel PR; Ransom TR; Henrich CJ; McKee TC; Goey AK; Cook KM; Figg WD; McMahon JB; Schnermann MJ; Gustafson KR
J Am Chem Soc; 2015 Apr; 137(16):5569-75. PubMed ID: 25892103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
